DHL is investing $70 million in its supply chain and logistics capabilities in North America to support its healthcare offering in the region.
The funding will be used to develop additional specialised warehousing infrastructure with new automation capabilities. This will include introducing collaborative robots from Locus Robotics, a company which counts DHL and Boots amongst its customers and recently netted $40 million in its latest funding round.
New customer sites will be developed in Memphis and Indianopolis.
The investment represents DHL doubling down on the direction it has taken during the Covid-19 pandemic with the expectation that recent developments will continue in the future.
Scott Cubbler, president of life sciences and healthcare at DHL Supply Chain North America, said: “DHL Supply Chain was already well-positioned to support our customers in recent months, thanks to our industry-leading footprint in North America and the investments we have made in fully licensed sites that meet their storage and handling requirements.
“At the same time, we recognise that demand will only intensify in the future as the market develops its response to the Covid-19 pandemic and adjusts to new ways of addressing patients’ everyday healthcare needs.
“By making this investment, which will also allow us to expand the use of efficiency-boosting new technologies, we are providing our customers with a platform for further growth, as well as the flexibility they need to respond as essential services in a fast-changing environment.”